$429 Million is the total value of Eagle Health Investments LP's 28 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 28.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SGEN | Buy | SEAGEN INC | $46,447,000 | +39.9% | 262,502 | +13.9% | 10.83% | +32.4% |
HUM | Buy | HUMANA INC | $37,535,000 | +10.7% | 80,191 | +3.0% | 8.75% | +4.8% |
UTHR | UNITED THERAPEUTICS CORP DEL | $37,523,000 | +31.3% | 159,238 | 0.0% | 8.75% | +24.3% | |
IQV | Buy | IQVIA HLDGS INC | $27,361,000 | +5.7% | 126,095 | +12.6% | 6.38% | -0.0% |
AZN | Sell | ASTRAZENECA PLCsponsored adr | $25,309,000 | -14.4% | 383,065 | -14.0% | 5.90% | -19.0% |
ARGX | Sell | ARGENX SEsponsored adr | $22,846,000 | +3.7% | 60,300 | -13.7% | 5.33% | -1.9% |
ILMN | New | ILLUMINA INC | $21,959,000 | – | 119,108 | +100.0% | 5.12% | – |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $21,787,000 | +1.7% | 149,380 | +13.8% | 5.08% | -3.8% |
NTRA | Buy | NATERA INC | $20,236,000 | +11.2% | 570,994 | +27.6% | 4.72% | +5.2% |
DXCM | Buy | DEXCOM INC | $17,671,000 | -11.2% | 237,100 | +509.5% | 4.12% | -16.0% |
INSP | Buy | INSPIRE MED SYS INC | $17,199,000 | -12.1% | 94,153 | +23.5% | 4.01% | -16.9% |
CANO | Buy | CANO HEALTH INC | $16,717,000 | -10.9% | 3,816,712 | +29.2% | 3.90% | -15.7% |
AMWL | Sell | AMERICAN WELL CORPcl a | $16,163,000 | +0.7% | 3,741,413 | -1.8% | 3.77% | -4.7% |
OM | Buy | OUTSET MED INC | $15,142,000 | +1.4% | 1,018,960 | +209.7% | 3.53% | -4.1% |
AXNX | AXONICS INC | $14,534,000 | -9.5% | 256,465 | 0.0% | 3.39% | -14.3% | |
ISRG | New | INTUITIVE SURGICAL INC | $13,153,000 | – | 65,530 | +100.0% | 3.07% | – |
AGIO | Buy | AGIOS PHARMACEUTICALS INC | $12,779,000 | +1.8% | 576,413 | +33.6% | 2.98% | -3.7% |
TXG | New | 10X GENOMICS INC | $11,819,000 | – | 261,200 | +100.0% | 2.76% | – |
ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $9,828,000 | -30.2% | 1,214,860 | +19.7% | 2.29% | -34.0% |
BPMC | BLUEPRINT MEDICINES CORP | $8,615,000 | -20.9% | 170,551 | 0.0% | 2.01% | -25.1% | |
GH | GUARDANT HEALTH INC | $6,130,000 | -39.1% | 151,960 | 0.0% | 1.43% | -42.4% | |
CMAX | CAREMAX INC | $2,595,000 | -51.4% | 714,755 | 0.0% | 0.60% | -54.0% | |
FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $1,825,000 | -8.6% | 261,423 | +97.9% | 0.42% | -13.6% |
BEAM | BEAM THERAPEUTICS INC | $1,119,000 | -32.4% | 28,900 | 0.0% | 0.26% | -36.0% | |
ARVN | ARVINAS INC | $968,000 | -37.5% | 23,000 | 0.0% | 0.23% | -40.7% | |
LYEL | LYELL IMMUNOPHARMA INC | $652,000 | +29.1% | 100,000 | 0.0% | 0.15% | +22.6% | |
OLK | OLINK HLDG ABsponsored ads | $608,000 | -13.9% | 40,000 | 0.0% | 0.14% | -18.4% | |
BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $394,000 | – | 23,500 | +100.0% | 0.09% | – |
CCCC | Exit | C4 THERAPEUTICS INC | $0 | – | -47,200 | -100.0% | -0.28% | – |
KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -37,000 | -100.0% | -0.39% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -52,000 | -100.0% | -1.05% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -82,144 | -100.0% | -5.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
NATERA INC | 12 | Q3 2023 | 8.5% |
ARGENX SE | 12 | Q3 2023 | 7.0% |
DEXCOM INC | 12 | Q3 2023 | 5.7% |
OUTSET MED INC | 12 | Q3 2023 | 7.3% |
AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-10-27 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.